Utama › Kanser Endometrium › Florida › Sarasota
Kajian klinikal Kanser Endometrium di Sarasota, FL
15 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi dalam dan sekitar Sarasota (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Mengambil pesertaFasa 3
- Florida Cancer Specialists - Sarasota Downtown, Sarasota
- FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery, Sarasota
- Sarasota Memorial Hospital, Sarasota
- dan 1 lagi
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Mengambil pesertaKajian pemerhatian
- Sarasota Memorial Health Care System, Sarasota
Study of AVZO-021 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Avenzo Therapeutics Recruiting Site, Sarasota
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Mengambil pesertaFasa 2
- Florida Cancer Specialists - Sarasota Downtown, Sarasota
- First Physicians Group-Sarasota, Sarasota
- Sarasota Memorial Hospital, Sarasota
- dan 1 lagi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- Florida Cancer Specialists, Sarasota
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Mengambil pesertaFasa 3
- SMH - Sarasota - Main Campus, Sarasota
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Mengambil pesertaKajian pemerhatian
- Physical Care Clinical Research, Sarasota
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Mengambil pesertaFasa 1
- SCRI FCS Sarasota, Sarasota
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Mengambil pesertaFasa 1
- SCRI - Florida Cancer Specialists, Sarasota
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Florida Cancer Specialists, Sarasota
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Mengambil pesertaFasa 1
- Florida Cancer Specialists, Sarasota
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Mengambil pesertaFasa 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Mengambil pesertaFasa 1
- Dren Investigational Site, Sarasota
Kajian Kanser Endometrium di bandar lain
- Houston, TX68 kajian
- New York City, NY52 kajian
- Boston, MA50 kajian
- Arlington, VA39 kajian
- Nashville, TN38 kajian
- Los Angeles, CA34 kajian
- St. Louis, MO29 kajian
- Philadelphia, PA28 kajian
- San Antonio, TX27 kajian
- Chicago, IL25 kajian
- Columbus, OH25 kajian
- Queens, NY25 kajian
Kajian lain di Sarasota
- Kanser Metastatik19 kajian
- Kanser Paru-paru Bukan Sel Kecil17 kajian
- Kanser Ovari16 kajian
- Kanser Kolorektal15 kajian
- Kanser Payudara12 kajian
- Kanser (semua jenis)11 kajian
- Kanser Payudara Triple-Negatif8 kajian
- Fibrilasi Atrium7 kajian
- Kanser Paru-paru7 kajian
- Kanser Pankreas7 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher6 kajian
- Penyakit Hati Steatotik6 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.